Drug Type Monoclonal antibody |
Synonyms LP 007, LP-007 |
Target |
Action inhibitors, stimulants |
Mechanism CD47 inhibitors(Cluster of differentiation 47 inhibitors), T lymphocytes stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | IND Application | China | 07 May 2022 | |
Solid tumor | IND Application | China | 07 May 2022 |